In addition, 81.4% (n = 35/43) of cancers with associated adenoma showed EPAS1 mRNA overexpression, whereas 59% (n = 23/39) of cancer without associated adenoma CRC had shown EPAS1 mRNA overexpression (p = 0.02; Table 2). Here, EPAS1 is linked to adenoma.